Bone is one of the common distant metastatic sites of lung cancer. Once diagnosed, many patients often panic, thinking that they have reached the late stage and there is no hope?
In fact, bone metastasis itself is not directly fatal; what truly warrants vigilance are a series of complications. However, with standardized treatment, long-term survival and good quality of life can still be achieved.
In this issue, we have invited Professor Yang Nong, a specially-appointed expert from Hainan Cancer Hospital/Affiliated Cancer Hospital of Hainan Medical University, to provide a detailed analysis of issues that patients are concerned about, helping everyone to cope with them calmly.
Part.1
Q: What does it mean to be diagnosed with lung cancer bone metastasis?
Professor Yang Nong: First of all, it must be clear that while bone metastasis of lung cancer is indeed more difficult to treat, it is by no means a terminal illness or a dead end.
The diagnosis of bone metastasis indicates that the condition has progressed to the advanced stage of lung cancer. However, advanced stage does not equate to terminal stage, nor does it mean that there is no treatment available. It is important for everyone to understand a core concept: bone metastasis itself does not directly lead to death. What truly endangers life and severely impacts quality of life are a series of bone-related events induced by bone metastasis, including complications such as pathological fractures, spinal compression, and intractable severe bone pain.
According to domestic clinical data, the median survival time for patients with lung cancer bone metastasis is approximately 11.53 months. Many patients may feel anxious upon seeing this figure, but it is important to understand that this is the average median value for all bone metastasis patients. In clinical practice, patient prognoses vary greatly, with some patients surviving only a few months, while many others can live with the tumor for several years. The core reason for this disparity lies in whether patients have received complete and standardized treatment.
Part.2
Question: How should lung cancer with bone metastasis be scientifically treated?
Professor Yang Nong: Based on the authoritative recommendations of domestic lung cancer diagnosis and treatment guidelines, the standardized treatment of lung cancer bone metastasis can be divided into three core steps, which progress step by step and comprehensively control the disease:
Step 1: Addressing the root cause, with controlling tumors throughout the body being the core
The primary goal of treatment is to initiate systemic therapy to suppress the primary tumor in the lungs and cancer cells spreading throughout the body, thereby halting disease progression at its source. For patients with driving gene mutation targets, targeted drug therapy is preferred; for those without corresponding targets, systemic regimens such as chemotherapy and immunotherapy can be chosen to stabilize the overall condition and prevent continued tumor spread.
Step 2: Protect the foundation, with bone protection therapy throughout the entire process
The application of bone-targeted drugs represents a significant advancement in the treatment of lung cancer with bone metastasis over the past decade. Specialized bone-protecting drugs such as bisphosphonates and denosumab can effectively strengthen bones, delay bone destruction, and significantly reduce the occurrence of severe complications such as pathological fractures and spinal cord compression.
The guidelines explicitly recommend that after a patient is diagnosed with bone metastasis, bone protection therapy should be initiated within 3 months if there are no medication contraindications, and it should be continued throughout the entire treatment cycle. Do not wait until severe symptoms such as severe bone pain or fractures occur before initiating intervention therapy.
Step 3: Treat acute conditions and alleviate pain through localized therapy
For patients who have developed acute conditions such as severe bone pain, pathological fractures, and spinal compression, timely localized targeted treatment is required. Through localized radiotherapy, surgical procedures, and other methods, rapid relief of pain, decompression of neural compression, and repair of bone damage can be achieved, minimizing patient suffering and preserving bodily functions and quality of life.
Lastly, He want to tell all patients: detecting lung cancer bone metastasis does not mean the sky is falling. The real impasse is self-abandonment. Today's tumor treatment has long entered a new era of living with cancer. Through scientific and standardized comprehensive treatment, we can precisely control tumor progression while protecting bone health and safeguarding quality of life, enabling long-term stable survival with the disease.
Expert Introduction
Yang Nong, Chief Physician, Doctoral Supervisor
Long-term employed experts from Hainan Cancer Hospital/Affiliated Cancer Hospital of Hainan Medical University and Hainan Chengmei Hospital
He currently serves as Vice President of the Second People's Hospital of Hunan Province, head of the oncology department, and director of the "Yang Nong Famous Doctor Clinic" / "Yang Nong Famous Doctor Expert Team Clinic". He is also a chief expert of the National Major Scientific and Technological Special Project, a member of the Lung Cancer Special Committee of the National Tumor Quality Control Center, the director of the Hunan Provincial Key Laboratory of Precision Diagnosis and Treatment of Lung Cancer, and the director of the Hunan Provincial Respiratory Tumor Clinical Medicine Research Center. He has been dedicated to precision targeted therapy for lung cancer and gastrointestinal tumors, as well as to challenging, recurrent, and drug-resistant clinical cases, scientific research, and teaching for nearly 30 years.
He has been honored with the title of "National Famous Doctor - Excellent Style" in the 6th edition, and has been recommended as "Annual Good Doctor" by patients across the country for 8 consecutive years, as well as being awarded the title of "First Brain Doctor - Famous Doctor". He has authored national guidelines, boasts over 500,000 followers across the internet, and has achieved over 120 million views in cancer prevention and treatment science popularization.
Medical expertise
Specialties: Precision treatment of lung cancer, breakthrough in refractory, recurrent, and drug-resistant cases with brain metastasis; individualized and precise treatment of brain metastases from lung cancer; early diagnosis of pulmonary nodules and lung cancer; personalized and comprehensive diagnosis and treatment of solid tumors; clinical trials of the latest immunotherapy/targeted therapy drugs.
With nearly 30 years of experience in precision immunotherapy for lung cancer, he has led nearly 400 Phase I-III clinical trials of new anticancer drugs (including Class 1 national new drugs), and is particularly skilled in treating complex cases such as refractory, recurrent, and drug-resistant conditions, as well as brain metastases.
He is also proficient in the comprehensive diagnosis and treatment of multiple cancer types, individualized, and interdisciplinary, covering a wide range of solid tumors (such as stomach, intestine, brain, etc.).
[Visit Information]
1. Clinic Hours and Location
August 23rd, 08:00-12:00
Sixth Consultation Area of Hainan Cancer Hospital
2. [Appointment registration]
Follow the official account of Hainan Cancer Hospital for "appointment registration"
3. Health consultation
18976324546
[Friendly Reminder]
To help the expert understand your condition quickly, please bring the following:
1. ID card, medical insurance card, and mobile phone
2. Accompanying direct relatives (with decision-making authority)
3. Relevant previous examination results, organized chronologically
4. Paper medical records from previous consultations
5. Surgical case slides, wax blocks, or 20-30 glass slides
6. Pathological diagnosis report
7. Hospitalization medical records
8. Recent relevant examination results
9. The patients current treatment plan
10. The most urgent questions to consult